| |
HC
|
MCI
|
AD
|
p - value
|
|---|
|
N
|
31
|
6
|
7
| |
|
Age (years)
|
71.8 (5.6)
|
68.3 (4.5)
|
71.3 (7.1)
|
0.40
|
|
Sex (F%)
|
58 %
|
50 %
|
28 %
|
0.41
|
|
APOEε4 %
|
19 %
|
0 %
|
43 %
|
0.20
|
|
MMSE (median IQR)
|
29 (1.5)
|
26 (2)
|
22 (3)
|
<0.0001
|
|
CDR (median IQR)
|
0 (0)
|
0.5 (0)
|
1 (0.25)
|
<0.0001
|
-
p–value determined by t-test (age), Chi square analyses (APOEε4 and sex) and Kruskal-Wallis tests (CDR score and MMSE)
-
N number, HC health control, MCI mild cognitive impairment, AD Alzheimer’s disease, APOEε4 apolipoprotein epsilon 4 allele, MMSE Mini–Mental State Examination, CDR Clinical Dementia Rating, IQR inter-quartile range
